Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
Condition:   Autosomal Dominant Polycystic Kidney Disease (ADPKD) Intervention:   Drug: Tolvaptan Sponsor:   Korea Otsuka Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2019 Category: Research Source Type: clinical trials

Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
Condition:   Polycystic Kidney Diseases Intervention:   Other: Dialysis Sponsor:   CHU de Reims Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials